Psoriasis is a chronic inflammatory disease characterized by squamous and erythematous
plaques on the skin and the involvement of the immune system. Global prevalence for …

Since the discovery of antibodies by Emil Von Behring and Shibasaburo Kitasato during the
19th century, their potential for use as biotechnological reagents has been exploited in …

Atopic dermatitis (AD) is a chronic inflammatory cutaneous disorder in which the skin is
affected by microbial dysbiosis. The role of commensal skin microbiota in AD is of great …

This study aimed to investigate the dose–response effect of Bifidobacterium breve
CCFM683 on relieving psoriasis and its underlying patterns. Specifically, the expression of …

Molecular communication between a pathogen and its host is crucial for a successful
interplay. Extracellular vesicles (EVs) act as mediators for the delivery of molecular signals …

Extracellular vesicles (EVs) are nano-sized particles released from cells into the
extracellular environment, and are separated from eukaryotic cells, bacteria, and other …

Psoriasis is a chronic immune-mediated condition that affects the skin and joints, with
current treatments still unable to offer a cure and long-term use of treatments posing health …

Our skin protects us from external threats including ultraviolet radiation, pathogens and
chemicals, and prevents excessive trans-epidermal water loss. These varied activities are …

Psoriasis is a chronic inflammatory disease affecting skin and joints characterized by a
chronically altered immune and inflammatory response. Several factors occur from the onset …

This study aimed to evaluate the effects of Bifidobacterium breve CCFM683 on psoriasis and
to investigate the underlying mechanisms. B. breve CCFM683 significantly ameliorated …